Gerresheimer GmbH is a leading provider of high-end glass and plastic products for the pharmaceutical and life sciences markets in the international market. The group started in 1864 and is headquartered in Düsseldorf, Germany. It has four major businesses: plastic systems, molded glass, tubular glass and life science research. The international market is mainly distributed in Europe, America and Asia, with 42 production plants worldwide. The production plant has more than 10,200 employees (including 4 factories in China with a total plant area of over 40,000 square meters). The group's main customers are world-renowned medical and medical technology companies such as Roche, AstraZeneca, Novartis, NovoNordisk, Pfizer, Abbott, Glaxo GSK, Bayer, ThermoFisher, Johnson & Johnson, Fresenus, Baxter, etc.

  The Gerresheimer Group was listed in Frankfurt, Germany in 2007 under the symbol: GXI and is one of the constituents of the German MDAX Index, which currently has a market value of 2.3 billion euros.